150
Participants
Start Date
September 15, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
December 31, 2027
This is an observational Study.
This is an observational study with no study-assigned interventions.Only observational measurements (blood collection for biomarker analysis) will be performed without modifying existing treatments.
Haiyan Pan
OTHER